openPR Logo
Press release

Von Willebrand Disease Treatment Market Trends, Outlook 2017-2025

03-20-2018 08:56 AM CET | Health & Medicine

Press release from: Medical Device Report

Von Willebrand Disease Treatment Market Trends, Outlook

Key players are organizing various symposiums to raise awareness about von Willebrand Disease and to increase brand visibility.

Key players in von Willebrand Disease (vWD) treatment market include Octapharma, Shire Plc, BDI Pharma, Baxalta, Ferring Pharmaceuticals, CSL Behring, and Grifols Therapeutics Inc. In 2017, Octapharma organized a symposium at the International Society on Thrombosis and Haemostasis (ISTH) congress in Berlin to support progress in lifelong treatment for patients with von Willebrand Disease (vWD) and to spread knowledge about their latest replacement therapy WILATE for treatment of von Willebrand Disease.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/1154

*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it.

North America is expected to dominate market due to increasing researches activities for treatment and diagnosis for von Willebrand Disease

Regional market for the von Willebrand Disease (vWD) treatment market by Coherent Market Insights is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America expected to hold the dominant position in vWD treatment market due to increase in research activities related to treatment and diagnosis of vWD. In 2017, BloodCenter of Wisconsin, which is a part of Versiti, launched a new assay for the measurement of von Willebrand (VWF) factor activity more accurately. Europe is expected to be the second largest market for von Willebrand Disease (vWD) treatment due to rapid marketing approval of vWD treatment drugs for marketing in Europe. In June, 2017 European Medicines Agency (EMA) granted marketing permission to VEYVONDI, which is replacement therapy for the treatment of vWD.

In 2017, European Medicines Agency (EMA) granted authorization for the marketing of VEYVONDI to prevent and treat von Willebrand Disease. VEYVONDI is a replacement therapy developed by Shire plc, which was FDA approved in 2015. Rapid marketing permission of drugs is expected to fuel Von Willebrand Disease (vWD) Treatment Market in near future. The major factor restraining the growth of von Willebrand Disease (vWD) treatment market is lack of awareness about disease and its diagnosis as it is a very rare disease.

Get More Details On this Report:
https://www.coherentmarketinsights.com/ongoing-insight/von-willebrand-disease-treatment-market-1154

“Catch us at 3rd International Conference on Separation + Drying Technologies for Milk & Whey at Cologne, March 19 and 20, 2018”

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentnews.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Von Willebrand Disease Treatment Market Trends, Outlook 2017-2025 here

News-ID: 984749 • Views: 180

More Releases from Medical Device Report

Arthroscopy Devices Market: Business Opportunities, Challenges And Companies Smi …
Coherent Market Insights has announced the addition of the “ Arthroscopy Devices Market Size Status and Forecast 2026”, The report classifies the global Arthroscopy Devices Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Arthroscopy Devices Market Speaker market, analyzes and researches the Arthroscopy Devices Market Speaker development status and
Light Therapy Market Is Growing With Major Key Players
Light therapy causes photo-oxidation and thus a primary treatment method for neonatal jaundice, eczema, and psoriasis. Narrow band ultraviolet (UVB) and broad band UVB phototherapy are issued for treatment of skin disorders. Increasing applications, favorable reimbursement policies, and insurance for such treatments is expected to boost demand for the light therapy. Treatment of acne by using LED light is gaining popularity, owing to various benefits such as cellular rejuvenation and
Halogen Surgical Ceiling Lights Market Progresses for Huge Profits by 2021
Halogen surgical ceiling lights or halogen operation lights are mainly used for assisting an operation in which a focused source of light is needed. These innovative lighting structures help in the improvement of surgical or procedural efficiency with its superior light source. If the main light source becomes dysfunctional, another light source is kept reserved in order to support in case of emergencies. A characteristic setup of halogen surgical ceiling
Cementless Neck Stems Market: Moving Towards a Brighter Future
Cementless stems are porous or coated implants used in total hip replacement. Through biologic fixation the bone tissues grows into the pores of the implant and secure it firmly. Cementless stems help reduce two major complications of hip replacement, namely, chances of infection and loosening of the prosthesis. The pores are designed to preserve the natural nutrition of femoral bone and facilitate rehabilitation by allowing for unrestricted blood flow. This

All 5 Releases


More Releases for Willebrand

Von Willebrand Disease Treatment Market Soaring Demand Assures Motivated Revenue …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their
Von Willebrand Disease Treatment Market - Global Industry Analysis,Overview, Siz …
Global Von Willebrand Disease Treatment Market In the recently published report, QY Research has provided a unique insight into the global Von Willebrand Disease Treatment market for the forecasted period of 7-years (2018-2025). The report has covered the significant aspects that are contributing the growth of the global Von Willebrand Disease Treatment market. The primary objective of this report is to highlight the various key market dynamics such as drivers, trends,
Von Willebrand Disease Treatment Market Revenue, Opportunity, Forecast and Value …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their
Von Willebrand Disease Treatment Market Expansion Projected to Gain an Uptick Du …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their
08-17-2018 | Health & Medicine
Fact.MR
Von Willebrand Disease Treatment Market Analysis Revealing Key Drivers, Cost Str …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their
Von Willebrand Disease Treatment Market to Make Great Impact in Near Future by 2 …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their